TrialJMIR mHealth and uHealth2026

WeChat-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes Mellitus: Multicenter Randomized Controlled Trial.

Chuanfen Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.